VolitionRx retains 284 Forterre shares for taxes

Q: How many VNRX shares were retained for Gael Forterre’s RSU tax obligations?

VolitionRx retained 284 shares for cancellation to satisfy tax-withholding obligations upon settlement of 687 restricted stock units.

Q: How many VNRX shares did Gael Forterre hold after the transaction?

Forterre directly held 16,284 shares. Reported indirect holdings included 250 shares held by his spouse and 1,625 shares managed by Armorica Partners, LLC, over which Forterre has voting and dispositive control.

VolitionRx Ltd. (VNRX) Chief Commercial Officer Gael Forterre reported 284 shares retained by the company for cancellation to satisfy tax-withholding obligations upon settlement of 687 restricted stock units.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

VolitionRx Ltd. (VNRX) Chief Commercial Officer Gael Forterre reported 284 shares retained by the company for cancellation to satisfy tax-withholding obligations upon settlement of 687 restricted stock units. The footnote states that neither Forterre nor VolitionRx sold shares in the transaction. Afterward, Forterre directly held 16,284 shares; reported indirect holdings included 250 shares held by his spouse and 1,625 shares managed by Armorica Partners, LLC. Forterre has voting and dispositive control over the Armorica Partners shares and disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

Tax Withholding: 284 shares

Tax Withholding 3 txns

Insider Forterre Gael

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock ^F1	284	$0.2529	$71.82
holding	Common Stock	--	--	--
holding	Common Stock ^F2	--	--	--

Holdings After Transaction: Common Stock — 16,284 shares (Direct); Common Stock — 250 shares (Indirect, By Spouse); Common Stock — 1,625 shares (Indirect, By Armorica Partners, LLC)

Footnotes (2)

F1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 687 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2. These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Key Figures

Shares retained for cancellation: 284 shares Restricted stock units: 687 units Direct shares following transaction: 16,284 shares +2 more

5 metrics

Shares retained for cancellation 284 shares To satisfy tax-withholding obligations

Restricted stock units 687 units Upon settlement

Direct shares following transaction 16,284 shares Gael Forterre

Spouse-held shares 250 shares Reported indirect holding

Armorica Partners-managed shares 1,625 shares Reported indirect holding

Key Terms

restricted stock units, tax withholding obligations, pecuniary interest

3 terms

restricted stock units financial

"settlement of 687 restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy the tax withholding obligations"

pecuniary interest financial

"except to the extent of his pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VNRX shares were retained for Gael Forterre’s RSU tax obligations?

VolitionRx retained 284 shares for cancellation to satisfy tax-withholding obligations upon settlement of 687 restricted stock units.

How many VNRX shares did Gael Forterre hold after the transaction?

Forterre directly held 16,284 shares. Reported indirect holdings included 250 shares held by his spouse and 1,625 shares managed by Armorica Partners, LLC, over which Forterre has voting and dispositive control.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/30/2026 - 05:01 PM Accepted by SEC EDGAR 09/30/2026 - 05:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forterre Gael

(Last)

(First)

(Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON

NEVADA

89014

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/28/2026		F		284⁽¹⁾	D	$0.2529	16,284	D
Common Stock								250	I	By Spouse
Common Stock								1,625	I	By Armorica Partners, LLC⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 687 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

2. These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

	/s/ Gael Forterre	09/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR